Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
18
NCT01966289
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Phase: Phase 1
Role: Collaborator
Start: Apr 14, 2014
Completion: Jun 6, 2020